Factors potentially associated with chemotherapy-induced anemia in patients with solid cancers

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 5057-5061

  Cheng, Ke ^a   Zhao, Feng ^a   Gao, Feng ^a   Dong, Hang ^a   Men, Hai Tao ^a   Chen, Ye ^a   Li, Long Hao ^a   Ge, Jun ^a   Tang, Jie ^a   Ding, Jing ^a   Chen, Xin ^a   Du, Yang ^a   Luo, Wu Xia ^a   Liu, Ji Yan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer; Chemotherapy; Cisplatin; Induced anemia; Leucopenia; Thrombocytopenia

Indexed keywords

EID: 84874012082     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.5057     Document Type: Article

References (25)

1. Aapro M, Jelkmann W, Constantinescu SN, Leyland-Jones B (2012). Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br J Cancer, 106, 1249-58.
2. Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y (2012). Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol, 23, 1954-62.
3. Abdel-Razeq HN (2004). Cancer-related anemia. Saudi Med J, 25, 15-20.
4. Achariyapota V, Benjapibal M, Chaopotong P (2010). Prevalence and incidence of anemia in Thai patients with gynecologic cancer. Asian Pac J Cancer Prev, 11, 1229-33.
5. Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E (2000). Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer, 82, 93-7.
6. Barrett-Lee PJ, Ludwig H, Birgegard G, et al (2006). Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey. Oncology, 70, 34-48.
7. Bohanes P, Yang D, Chhibar RS, et al (2012). Influence of sex on the survival of patients with esophageal cancer. J Clin Oncol, 30, 2265-72.
8. Caro JJ, Salas M, Ward A, Goss G (2001). Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer, 91, 2214-21.
9. Gao F, Cheng K, Zhao F, et al (2011). Prevalence and characteristics of anemia in patients with solid cancers at diagnosis in southwest China. Asian Pac J Cancer Prev, 12, 2825-8.
10. Groopman JE, Itri LM (1999). Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst, 91, 1616-34.
11. Hassan BA, Yusoff ZB (2011). Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. Asian Pac J Cancer Prev, 12, 1573-6.
12. Hassan BA, Yusoff ZB, Hassali MA, Othman SB (2011). Association and correlation of different chemotherapeutic regimens and doses with onset and severity of anemia among solid cancer patients. Asian Pac J Cancer Prev, 12, 2753-8.
13. Knight K, Wade S, Balducci L (2004). Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med, 116, S11-26.
14. Kosmidis P, Krzakowski M (2005). Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS). Lung Cancer, 50, 401-12.
15. Ludwig H, Van Belle S, Barrett-Lee P, et al (2004). The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 40, 2293-306.
16. Mercadante S, Gebbia V, Marrazzo A, Filosto S (2000). Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev, 26, 303-11.
17. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL (1990). Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med, 322, 1689-92.
18. Owonikoko TK, Ragin CC, Belani CP, et al (2007). Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol, 25, 5570-7.
19. Pongsanon K, Benjapibal M, Ruengkhachorn I (2011). Prognostic significance of hemoglobin levels in patients with primary epithelial ovarian carcinoma undergoing platinum-based chemotherapy. Asian Pac J Cancer Prev, 12, 131-6.
20. Rothmann SA, Weick JK (1981). Cisplatin toxicity for erythroid precursors. N Engl J Med, 304, 360.
21. Spivak JL, Gascon P, Ludwig H (2009). Anemia management in oncology and hematology. Oncologist, 14, 43-56.
22. Steensma DP (2008). Is anemia of cancer different from chemotherapy-induced anemia. J Clin Oncol, 26, 1022-4.
23. Tchekmedyian NS (2002). Anemia in cancer patients: significance, epidemiology, and current therapy. Oncology (Williston Park), 16, 17-24.
24. Weiss G, Goodnough LT (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23.
25. Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90.